Stage-dependent gray matter morphological alterations across the clinical spectrum of depressive disorder.

J Affect DisordOct 20, 2026 (epub)

Kun Xu, Baolin Wu, Ziru Zhao et al.

✦ AI-curated · Sources linked

In 30 seconds

This quantitative voxel-wise meta-analysis examined gray matter volume (GMV) patterns across subthreshold depression, first-episode drug-naïve depression, and long-term major depressive disorder, comparing each group with controls and assessing differences across stages. It included 12 studies of subthreshold depression (467 individuals), 19 of first-episode depression (854 patients), and 14 of long-term depression (525 patients). Early-stage groups showed mixed GMV increases and decreases, whereas long-term MDD showed reductions in the paracingulate gyrus and left middle temporal gyrus extending to the insula. Cross-stage comparisons indicated progressive divergence in prefrontal and temporal regions.

Key findings

  • The meta-analysis included 12 subthreshold-depression studies (467 individuals), 19 first-episode studies (854 patients), and 14 long-term-depression studies (525 patients).
  • Subthreshold and first-episode depression showed mixed GMV increases and decreases, mainly in emotional and default mode network regions.
  • Long-term MDD showed GMV reductions in the paracingulate gyrus and left middle temporal gyrus extending to the insula.
  • Prefrontal and temporal GMV alterations diverged progressively across stages; meta-regression found stage-specific associations with clinical characteristics.

Why it matters

The findings suggest that structural brain differences associated with depression may vary across illness stages rather than follow one uniform pattern. This stage-specific perspective may help frame research into vulnerability and illness progression, while the meta-analysis does not establish that the observed GMV changes cause depression or predict an individual’s course.

What to keep in mind

The findings synthesize voxel-based morphometry studies and therefore depend on the included studies and their methods; the abstract does not report prospective validation of the proposed vulnerability markers.

Source

Published in J Affect Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.